Market Reports Center

Global Next-Generation Biologics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023


Report Details

Global Next-Generation Biologics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

SKU GIRJAN101946
Category Life Sciences
Publisher GlobalInfoResearch
Pages 118
Published Jan-19
Request Discount Pay by Wire/Invoice

Description

Next generation biologics refers to some noval drugs, biotreatment and some breakthroght biomaterials etc.

Scope of the Report:
This report studies the Next-Generation Biologics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Next-Generation Biologics market by product type and applications/end industries.
The increasing demand for antibody drug conjugates (ADCs) is one of the major factors driving this market’s growth. ADCs are highly effective cytotoxic drugs linked to an mAbs. These drugs have shown to be potent and efficient in treating diseases, including cancers and hematological malignancies.
The global Next-Generation Biologics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Next-Generation Biologics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers
Allergan
Bayer
Biogen Idec
Eli Lilly
Kyowa Hakko Kirin
Molecular Partners
Novo Nordisk
Pfizer
Roche
Sanofi

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Antibodies
Regenerative medicine
Insulins
Growth hormones
Other

Market Segment by Applications, can be divided into
Medical
Scientific Research
Other


News/Press Release

Table of Content

Table of Contents

1 Next-Generation Biologics Market Overview
1.1 Product Overview and Scope of Next-Generation Biologics
1.2 Classification of Next-Generation Biologics by Types
1.2.1 Global Next-Generation Biologics Revenue Comparison by Types (2017-2023)
1.2.2 Global Next-Generation Biologics Revenue Market Share by Types in 2017
1.2.3 Antibodies
1.2.4 Regenerative medicine
1.2.5 Insulins
1.2.6 Growth hormones
1.2.7 Other
1.3 Global Next-Generation Biologics Market by Application
1.3.1 Global Next-Generation Biologics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Medical
1.3.3 Scientific Research
1.3.4 Other
1.4 Global Next-Generation Biologics Market by Regions
1.4.1 Global Next-Generation Biologics Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Next-Generation Biologics Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Next-Generation Biologics Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Next-Generation Biologics Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Next-Generation Biologics Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Next-Generation Biologics Status and Prospect (2013-2023)
1.5 Global Market Size of Next-Generation Biologics (2013-2023)
2 Manufacturers Profiles
2.1 Allergan
2.1.1 Business Overview
2.1.2 Next-Generation Biologics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Allergan Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bayer
2.2.1 Business Overview
2.2.2 Next-Generation Biologics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bayer Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
2.3 Biogen Idec
2.3.1 Business Overview
2.3.2 Next-Generation Biologics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Biogen Idec Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Eli Lilly
2.4.1 Business Overview
2.4.2 Next-Generation Biologics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Eli Lilly Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
2.5 Kyowa Hakko Kirin
2.5.1 Business Overview
2.5.2 Next-Generation Biologics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Kyowa Hakko Kirin Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
2.6 Molecular Partners
2.6.1 Business Overview
2.6.2 Next-Generation Biologics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Molecular Partners Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
2.7 Novo Nordisk
2.7.1 Business Overview
2.7.2 Next-Generation Biologics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Novo Nordisk Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
2.8 Pfizer
2.8.1 Business Overview
2.8.2 Next-Generation Biologics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Pfizer Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
2.9 Roche
2.9.1 Business Overview
2.9.2 Next-Generation Biologics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Roche Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
2.10 Sanofi
2.10.1 Business Overview
2.10.2 Next-Generation Biologics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sanofi Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
3 Global Next-Generation Biologics Market Competition, by Players
3.1 Global Next-Generation Biologics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Next-Generation Biologics Players Market Share
3.2.2 Top 10 Next-Generation Biologics Players Market Share
3.3 Market Competition Trend
4 Global Next-Generation Biologics Market Size by Regions
4.1 Global Next-Generation Biologics Revenue and Market Share by Regions
4.2 North America Next-Generation Biologics Revenue and Growth Rate (2013-2018)
4.3 Europe Next-Generation Biologics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Next-Generation Biologics Revenue and Growth Rate (2013-2018)
4.5 South America Next-Generation Biologics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Next-Generation Biologics Revenue and Growth Rate (2013-2018)
5 North America Next-Generation Biologics Revenue by Countries
5.1 North America Next-Generation Biologics Revenue by Countries (2013-2018)
5.2 USA Next-Generation Biologics Revenue and Growth Rate (2013-2018)
5.3 Canada Next-Generation Biologics Revenue and Growth Rate (2013-2018)
5.4 Mexico Next-Generation Biologics Revenue and Growth Rate (2013-2018)
6 Europe Next-Generation Biologics Revenue by Countries
6.1 Europe Next-Generation Biologics Revenue by Countries (2013-2018)
6.2 Germany Next-Generation Biologics Revenue and Growth Rate (2013-2018)
6.3 UK Next-Generation Biologics Revenue and Growth Rate (2013-2018)
6.4 France Next-Generation Biologics Revenue and Growth Rate (2013-2018)
6.5 Russia Next-Generation Biologics Revenue and Growth Rate (2013-2018)
6.6 Italy Next-Generation Biologics Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Next-Generation Biologics Revenue by Countries
7.1 Asia-Pacific Next-Generation Biologics Revenue by Countries (2013-2018)
7.2 China Next-Generation Biologics Revenue and Growth Rate (2013-2018)
7.3 Japan Next-Generation Biologics Revenue and Growth Rate (2013-2018)
7.4 Korea Next-Generation Biologics Revenue and Growth Rate (2013-2018)
7.5 India Next-Generation Biologics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Next-Generation Biologics Revenue and Growth Rate (2013-2018)
8 South America Next-Generation Biologics Revenue by Countries
8.1 South America Next-Generation Biologics Revenue by Countries (2013-2018)
8.2 Brazil Next-Generation Biologics Revenue and Growth Rate (2013-2018)
8.3 Argentina Next-Generation Biologics Revenue and Growth Rate (2013-2018)
8.4 Colombia Next-Generation Biologics Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Next-Generation Biologics by Countries
9.1 Middle East and Africa Next-Generation Biologics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Next-Generation Biologics Revenue and Growth Rate (2013-2018)
9.3 UAE Next-Generation Biologics Revenue and Growth Rate (2013-2018)
9.4 Egypt Next-Generation Biologics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Next-Generation Biologics Revenue and Growth Rate (2013-2018)
9.6 South Africa Next-Generation Biologics Revenue and Growth Rate (2013-2018)
10 Global Next-Generation Biologics Market Segment by Type
10.1 Global Next-Generation Biologics Revenue and Market Share by Type (2013-2018)
10.2 Global Next-Generation Biologics Market Forecast by Type (2018-2023)
10.3 Antibodies Revenue Growth Rate (2013-2023)
10.4 Regenerative medicine Revenue Growth Rate (2013-2023)
10.5 Insulins Revenue Growth Rate (2013-2023)
10.6 Growth hormones Revenue Growth Rate (2013-2023)
10.7 Other Revenue Growth Rate (2013-2023)
11 Global Next-Generation Biologics Market Segment by Application
11.1 Global Next-Generation Biologics Revenue Market Share by Application (2013-2018)
11.2 Next-Generation Biologics Market Forecast by Application (2018-2023)
11.3 Medical Revenue Growth (2013-2018)
11.4 Scientific Research Revenue Growth (2013-2018)
11.5 Other Revenue Growth (2013-2018)
12 Global Next-Generation Biologics Market Size Forecast (2018-2023)
12.1 Global Next-Generation Biologics Market Size Forecast (2018-2023)
12.2 Global Next-Generation Biologics Market Forecast by Regions (2018-2023)
12.3 North America Next-Generation Biologics Revenue Market Forecast (2018-2023)
12.4 Europe Next-Generation Biologics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Next-Generation Biologics Revenue Market Forecast (2018-2023)
12.6 South America Next-Generation Biologics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Next-Generation Biologics Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Figures

List of Tables and Figures

Figure Next-Generation Biologics Picture
Table Product Specifications of Next-Generation Biologics
Table Global Next-Generation Biologics and Revenue (Million USD) Market Split by Product Type
Figure Global Next-Generation Biologics Revenue Market Share by Types in 2017
Figure Antibodies Picture
Figure Regenerative medicine Picture
Figure Insulins Picture
Figure Growth hormones Picture
Figure Other Picture
Table Global Next-Generation Biologics Revenue (Million USD) by Application (2013-2023)
Figure Next-Generation Biologics Revenue Market Share by Applications in 2017
Figure Medical Picture
Figure Scientific Research Picture
Figure Other Picture
Table Global Market Next-Generation Biologics Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Next-Generation Biologics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Next-Generation Biologics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Next-Generation Biologics Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Next-Generation Biologics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Next-Generation Biologics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Next-Generation Biologics Revenue (Million USD) and Growth Rate (2013-2023)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Next-Generation Biologics Type and Applications
Table Allergan Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Next-Generation Biologics Type and Applications
Table Bayer Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
Table Biogen Idec Basic Information, Manufacturing Base and Competitors
Table Biogen Idec Next-Generation Biologics Type and Applications
Table Biogen Idec Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Next-Generation Biologics Type and Applications
Table Eli Lilly Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
Table Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors
Table Kyowa Hakko Kirin Next-Generation Biologics Type and Applications
Table Kyowa Hakko Kirin Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
Table Molecular Partners Basic Information, Manufacturing Base and Competitors
Table Molecular Partners Next-Generation Biologics Type and Applications
Table Molecular Partners Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
Table Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk Next-Generation Biologics Type and Applications
Table Novo Nordisk Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Next-Generation Biologics Type and Applications
Table Pfizer Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Next-Generation Biologics Type and Applications
Table Roche Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Next-Generation Biologics Type and Applications
Table Sanofi Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
Table Global Next-Generation Biologics Revenue (Million USD) by Players (2013-2018)
Table Global Next-Generation Biologics Revenue Share by Players (2013-2018)
Figure Global Next-Generation Biologics Revenue Share by Players in 2016
Figure Global Next-Generation Biologics Revenue Share by Players in 2017
Figure Global Top 5 Players Next-Generation Biologics Revenue Market Share in 2017
Figure Global Top 10 Players Next-Generation Biologics Revenue Market Share in 2017
Figure Global Next-Generation Biologics Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Next-Generation Biologics Revenue (Million USD) by Regions (2013-2018)
Table Global Next-Generation Biologics Revenue Market Share by Regions (2013-2018)
Figure Global Next-Generation Biologics Revenue Market Share by Regions (2013-2018)
Figure Global Next-Generation Biologics Revenue Market Share by Regions in 2017
Figure North America Next-Generation Biologics Revenue and Growth Rate (2013-2018)
Figure Europe Next-Generation Biologics Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Next-Generation Biologics Revenue and Growth Rate (2013-2018)
Figure South America Next-Generation Biologics Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Next-Generation Biologics Revenue and Growth Rate (2013-2018)
Table North America Next-Generation Biologics Revenue by Countries (2013-2018)
Table North America Next-Generation Biologics Revenue Market Share by Countries (2013-2018)
Figure North America Next-Generation Biologics Revenue Market Share by Countries (2013-2018)
Figure North America Next-Generation Biologics Revenue Market Share by Countries in 2017
Figure USA Next-Generation Biologics Revenue and Growth Rate (2013-2018)
Figure Canada Next-Generation Biologics Revenue and Growth Rate (2013-2018)
Figure Mexico Next-Generation Biologics Revenue and Growth Rate (2013-2018)
Table Europe Next-Generation Biologics Revenue (Million USD) by Countries (2013-2018)
Figure Europe Next-Generation Biologics Revenue Market Share by Countries (2013-2018)
Figure Europe Next-Generation Biologics Revenue Market Share by Countries in 2017
Figure Germany Next-Generation Biologics Revenue and Growth Rate (2013-2018)
Figure UK Next-Generation Biologics Revenue and Growth Rate (2013-2018)
Figure France Next-Generation Biologics Revenue and Growth Rate (2013-2018)
Figure Russia Next-Generation Biologics Revenue and Growth Rate (2013-2018)
Figure Italy Next-Generation Biologics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Next-Generation Biologics Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Next-Generation Biologics Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Next-Generation Biologics Revenue Market Share by Countries in 2017
Figure China Next-Generation Biologics Revenue and Growth Rate (2013-2018)
Figure Japan Next-Generation Biologics Revenue and Growth Rate (2013-2018)
Figure Korea Next-Generation Biologics Revenue and Growth Rate (2013-2018)
Figure India Next-Generation Biologics Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Next-Generation Biologics Revenue and Growth Rate (2013-2018)
Table South America Next-Generation Biologics Revenue by Countries (2013-2018)
Table South America Next-Generation Biologics Revenue Market Share by Countries (2013-2018)
Figure South America Next-Generation Biologics Revenue Market Share by Countries (2013-2018)
Figure South America Next-Generation Biologics Revenue Market Share by Countries in 2017
Figure Brazil Next-Generation Biologics Revenue and Growth Rate (2013-2018)
Figure Argentina Next-Generation Biologics Revenue and Growth Rate (2013-2018)
Figure Colombia Next-Generation Biologics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Next-Generation Biologics Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Next-Generation Biologics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Next-Generation Biologics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Next-Generation Biologics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Next-Generation Biologics Revenue and Growth Rate (2013-2018)
Figure UAE Next-Generation Biologics Revenue and Growth Rate (2013-2018)
Figure Egypt Next-Generation Biologics Revenue and Growth Rate (2013-2018)
Figure Nigeria Next-Generation Biologics Revenue and Growth Rate (2013-2018)
Figure South Africa Next-Generation Biologics Revenue and Growth Rate (2013-2018)
Table Global Next-Generation Biologics Revenue (Million USD) by Type (2013-2018)
Table Global Next-Generation Biologics Revenue Share by Type (2013-2018)
Figure Global Next-Generation Biologics Revenue Share by Type (2013-2018)
Figure Global Next-Generation Biologics Revenue Share by Type in 2017
Table Global Next-Generation Biologics Revenue Forecast by Type (2018-2023)
Figure Global Next-Generation Biologics Market Share Forecast by Type (2018-2023)
Figure Global Antibodies Revenue Growth Rate (2013-2018)
Figure Global Regenerative medicine Revenue Growth Rate (2013-2018)
Figure Global Insulins Revenue Growth Rate (2013-2018)
Figure Global Growth hormones Revenue Growth Rate (2013-2018)
Figure Global Other Revenue Growth Rate (2013-2018)
Table Global Next-Generation Biologics Revenue by Application (2013-2018)
Table Global Next-Generation Biologics Revenue Share by Application (2013-2018)
Figure Global Next-Generation Biologics Revenue Share by Application (2013-2018)
Figure Global Next-Generation Biologics Revenue Share by Application in 2017
Table Global Next-Generation Biologics Revenue Forecast by Application (2018-2023)
Figure Global Next-Generation Biologics Market Share Forecast by Application (2018-2023)
Figure Global Medical Revenue Growth Rate (2013-2018)
Figure Global Scientific Research Revenue Growth Rate (2013-2018)
Figure Global Other Revenue Growth Rate (2013-2018)
Figure Global Next-Generation Biologics Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Next-Generation Biologics Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Next-Generation Biologics Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Next-Generation Biologics Revenue Market Forecast (2018-2023)
Figure Europe Next-Generation Biologics Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Next-Generation Biologics Revenue Market Forecast (2018-2023)
Figure South America Next-Generation Biologics Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Next-Generation Biologics Revenue Market Forecast (2018-2023)

Companies Profiled

Allergan
Bayer
Biogen Idec
Eli Lilly
Kyowa Hakko Kirin
Molecular Partners
Novo Nordisk
Pfizer
Roche
Sanofi

Market Reports Center © Copyright 2019 All rights reserved.

wire transfer
HDFC
ssl